V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 230001916 | 230009271 | 1.67 | 90 | null | 2022-02-01 | 2022-02-01 | Liposomal Doxorubicin (Caelyx) | 02 | null | LIPOSOMAL DOXORUBICIN | 100592802 |
| 230001917 | 230009272 | 1.63 | 59.3 | Palliative (P) | 2017-06-22 | 2017-07-01 | GemCarbo Days 1+8 | 02 | N | CARBOPLATIN + GEMCITABINE | 101627896 |
| 230001925 | 230009274 | 1.6 | 55 | null | null | 2020-04-14 | null | null | null | CARBOPLATIN | 100276572 |
| 230001926 | 230009275 | 1.65 | 73.1 | null | null | 2019-03-03 | CISPLATIN + ETOPOSIDE | 02 | null | TRIAL UNSPECIFIED | 101443646 |
| 230001928 | 230009276 | 1.62 | 50.1 | null | 2021-09-24 | 2021-09-27 | Olaparib | 02 | null | OLAPARIB | 100082218 |
| 230001930 | 230009277 | 1.55 | 66.1 | Neo-adjuvant (N) | null | 2021-04-12 | Liposomal Doxorubicin 40mg/m2 | 02 | N | LIPOSOMAL DOXORUBICIN | 101751886 |
| 230001932 | 230009278 | 1.66 | 70.5 | null | 2021-03-03 | 2021-07-07 | null | null | null | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL | 100578660 |
| 230001938 | 230009280 | null | null | null | 2020-05-01 | 2020-05-14 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101134945 |
| 230001939 | 230009281 | 1.57 | 113 | null | 2017-11-26 | 2017-12-12 | Carboplatin AUC 2 - 5 | 02 | null | CARBOPLATIN | 100510619 |
| 230001942 | 230009284 | 1.5 | 0 | null | null | 2020-03-23 | Rucaparib | 02 | null | RUCAPARIB | 100920468 |
| 230001945 | 230009285 | 1.6 | 63.4 | Neo-adjuvant (N) | null | 2022-03-14 | null | 02 | N | TRIAL UNSPECIFIED | 101799109 |
| 230001947 | 230009286 | 1.62 | 106.2 | null | null | 2020-08-05 | Carboplatin AUC 2 - 5 | 02 | null | CARBOPLATIN | 100662507 |
| 230001950 | 230009287 | null | null | null | null | 2017-03-01 | null | null | null | TRIAL UNSPECIFIED | 101174225 |
| 230001952 | 230009288 | 1.66 | 54.2 | null | null | 2022-04-27 | null | N | null | CISPLATIN + LIPOSOMAL DOXORUBICIN | 101302845 |
| 230001953 | 230009289 | 1.72 | 63.5 | Curative (C) | 2019-08-29 | 2019-08-29 | null | null | N | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL | 101786368 |
| 230001955 | 230009291 | 1.73 | 55 | Adjuvant (A) | 2021-02-04 | 2021-03-06 | CARBOPLATIN + GEMCITABINE | 02 | Y | CARBOPLATIN + GEMCITABINE | 100203421 |
| 230001956 | 230009292 | 1.6 | 65 | null | 2019-07-26 | 2019-08-05 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 100717977 |
| 230001965 | 230009295 | null | null | null | 2017-07-26 | 2017-08-29 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 100648169 |
| 230001971 | 230009297 | null | 68.4 | null | 2019-04-04 | 2020-09-27 | Bevacizumab | 02 | null | BEVACIZUMAB | 101171132 |
| 230001976 | 230009298 | 1.62 | 45.2 | Adjuvant (A) | 2021-04-21 | 2022-01-05 | CISPLATIN + GEMCITABINE | 02 | N | CISPLATIN | 101770881 |
| 230001977 | 230009299 | 1.63 | 69 | null | 2021-06-20 | 2021-06-27 | Carboplatin AUC 6 - 10 | 02 | null | CARBOPLATIN | 101623618 |
| 230001978 | 230009300 | null | null | null | null | 2020-07-27 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100327927 |
| 230001982 | 230009301 | 1.65 | 99.8 | null | 2018-01-09 | 2018-01-10 | Paclitaxel 7 day | 02 | null | PACLITAXEL | 101163629 |
| 230001986 | 230009303 | 1.5 | 48.15 | Palliative (P) | null | 2021-03-15 | Rucaparib | 02 | N | RUCAPARIB | 101362307 |
| 230001988 | 230009304 | null | null | Curative (C) | 2021-10-03 | 2021-10-24 | null | 02 | N | TRIAL UNSPECIFIED | 100478120 |
| 230001993 | 230009305 | null | 92.85 | null | 2016-08-06 | 2016-08-06 | Liposomal Doxorubicin 40mg/m2 | 02 | null | LIPOSOMAL DOXORUBICIN | 101697484 |
| 230001999 | 230009306 | 1.68 | 68 | Curative (C) | null | 2020-04-24 | Carboplatin AUC 6 - 10 | 02 | N | CARBOPLATIN | 100523889 |
| 230002014 | 230009308 | 1.65 | null | Palliative (P) | null | 2021-01-14 | Niraparib | 02 | N | NIRAPARIB | 100142846 |
| 230002022 | 230009310 | null | 69.3 | Palliative (P) | null | 2019-07-06 | null | null | null | CARBOPLATIN | 101427882 |
| 230002027 | 230009312 | 1.59 | 78 | Palliative (P) | 2020-07-24 | 2020-07-26 | CARBOPLATIN | 02 | N | CARBOPLATIN | 101310432 |
| 230002031 | 230009313 | 1.62 | 52.3 | null | 2021-10-19 | 2021-11-05 | null | 02 | null | CISPLATIN | 101678575 |
| 230002037 | 230009314 | 1.67 | 59 | null | 2020-03-21 | 2020-05-23 | CARBOPLATIN | 02 | null | CARBOPLATIN | 100762527 |
| 230002043 | 230009315 | null | null | null | 2019-10-09 | 2019-10-11 | Bevacizumab 7.5mg/kg | 02 | null | BEVACIZUMAB | 101645607 |
| 230002050 | 230009317 | 1.8 | 67 | null | null | 2019-10-22 | Liposomal Doxorubicin 40mg/m2 | 02 | null | LIPOSOMAL DOXORUBICIN | 101559296 |
| 230002054 | 230009319 | 1.62 | 83.9 | null | 2020-02-09 | 2020-02-19 | PACLITAXEL | 02 | null | PACLITAXEL | 100789824 |
| 230002061 | 230009320 | null | null | Palliative (P) | 2022-05-09 | 2022-05-14 | Liposomal Doxorubicin 40mg/m2 | 02 | N | LIPOSOMAL DOXORUBICIN | 100507338 |
| 230002064 | 230009321 | 1.58 | 72.6 | null | 2021-02-06 | 2021-02-21 | Niraparib | 02 | null | NIRAPARIB | 100781182 |
| 230002065 | 230009322 | 1.65 | 93.8 | null | 2017-03-04 | 2017-03-04 | Bevacizumab 7.5mg/kg | 02 | null | BEVACIZUMAB | 101004899 |
| 230002067 | 230009323 | null | null | null | 2019-06-04 | 2019-06-15 | CVP R | 02 | null | ICON8B TRIAL | 101408196 |
| 230002071 | 230009325 | 1.69 | 67 | null | 2020-07-25 | 2020-08-29 | CARBOPLATIN | 02 | null | CARBOPLATIN | 100560032 |
| 230002077 | 230009329 | 1.74 | 60.5 | Palliative (P) | 2017-11-08 | 2017-11-19 | PACLITAXEL | 02 | N | PACLITAXEL | 101474197 |
| 230002084 | 230009331 | 1.63 | 54 | Palliative (P) | 2018-07-02 | 2018-07-17 | Carboplatin + Liposomal Doxorubicin | 02 | N | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100495181 |
| 230002089 | 230009333 | 1.66 | 67.3 | Palliative (P) | 2020-10-07 | 2020-11-12 | Carboplatin AUC 6 - 10 | 02 | N | CARBOPLATIN | 101402009 |
| 230002090 | 230009334 | 1.56 | 95.7 | null | 2021-09-18 | 2021-09-25 | GemCarbo Days 1+8 | 02 | null | CARBOPLATIN + GEMCITABINE | 101765445 |
| 230002091 | 230009335 | null | null | null | 2021-11-06 | 2021-11-08 | PACLITAXEL | 02 | null | PACLITAXEL | 100716171 |
| 230002092 | 230009336 | 1.58 | 65 | null | 2020-11-24 | 2020-11-28 | Rucaparib | 02 | null | RUCAPARIB | 100758939 |
| 230002093 | 230009337 | 1.6 | 74.5 | null | null | 2018-10-03 | Olaparib | 02 | null | OLAPARIB | 101534372 |
| 230002094 | 230009338 | 1.53 | null | Palliative (P) | 2019-11-13 | 2019-11-13 | Bevacizumab+Carbo+Pacliaxel | 02 | N | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL | 100577680 |
| 230002095 | 230009339 | 1.55 | 64.3 | null | 2020-06-11 | 2020-08-11 | Carboplatin + Liposomal Doxorubicin | 02 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100288931 |
| 230002098 | 230009341 | null | null | null | null | 2022-03-09 | null | null | null | CISPLATIN + ETOPOSIDE | 101686199 |